Comparative Testing of Various Pancreatic Cancer Stem Cells Results in a Novel Class of Pancreatic-Cancer–Initiating Cells

No systemic therapy is effective against pancreatic cancer (PC). Pancreatic cancer stem cells (PCSC) are hypothesized to account for therapeutic resistance. Several PCSC subpopulations were reported, each characterized by different markers. To be able to target PCSC, we sought to better define this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jaiswal, Kshama R., Xin, Hong-Wu, Anderson, Andrew, Wiegand, Gordon, Kim, Bo, Miller, Tyler, Hari, Danielle, Ray, Satyajit, Koizumi, Tomotake, Rudloff, Udo, Thorgeirsson, Snorri S., Avital, Itzhak
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490042/
https://ncbi.nlm.nih.gov/pubmed/22963768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scr.2012.08.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares